Invasive breast carcinoma - IARC

1750. Maluf FC, Sabbatini P, Schwartz L,
Xia J, Aghajanian C (2001). Endometrial
stromal sarcoma: objective response to
letrozole. Gynecol Oncol 82: 384-388.
1751. Maluf HM, Koerner FC (1994).
Carcinomas of the breast with endocrine
differentiation: a review. Virchows Arch
425: 449-457.
1752. Maluf HM, Koerner FC (1995). Solid
papillary carcinoma of the breast. A form
of intraductal carcinoma with endocrine
differentiation frequently associated with
mucinous carcinoma. Am J Surg Pathol 19:
1237-1244.
1753. Mambo NC, Burke JS, Butler JJ
(1977). Primary malignant lymphomas of
the breast. Cancer 39: 2033-2040.
1754. Man S, Ellis IO, Sibbering M, Blamey
RW, Brook JD (1996). High levels of allele
loss at the FHIT and ATM genes in noncomedo
ductal carcinoma in situ and
grade I tubular invasive breast cancers.
Cancer Res 56: 5484-5489.
1755. Mandai M, Konishi I, Kuroda H,
Komatsu T, Yamamoto S, Nanbu K,
Matsushita K, Fukumoto M, Yamabe H,
Mori T (1998). Heterogeneous distribution
of K-ras-mutated epithelia in mucinous
ovarian tumors with special reference to
histopathology. Hum Pathol 29: 34-40.
1756. Manegold E, Tietze L, Gunther K,
Fleischer A, Amo-Takyi BK, Schroder W,
Handt S (2001). Trisomy 8 as sole karyotypic
aberration in an ovarian metastasizing
Sertoli-Leydig cell tumor. Hum Pathol 32:
559-562.
1757. Manhoff DT, Schiffman R, Haupt HM
(1995). Adenoid cystic carcinoma of the
uterine cervix with malignant stroma. An
unusual variant of carcinosarcoma? Am J
Surg Pathol 19: 229-233.
1758. Manini C, Pietribiasi F, Sapino A,
Donadio S (1998). [Serous cystadenocarcinoma
of the ovary with simultaneous
breast metastases. Description of a case].
Pathologica 90: 152-155.
1759. Manivel JC, Niehans G, Wick MR,
Dehner LP (1987). Intermediate trophoblast
in germ cell neoplasms. Am J Surg Pathol
11: 693-701.
1760. Manjer J, Malina J, Berglund G,
Bondeson L, Garne JP, Janzon L (2001).
Increased incidence of small and well-differentiated
breast tumours in postmenopausal
women following hormonereplacement
therapy. Int J Cancer 9 2 :
919-922.
1761. Mannion C, Park WS, Man YG,
Zhuang Z, Albores-Saavedra J, Tavassoli
FA (1998). Endocrine tumors of the cervix:
morphologic assessment, expression of
human papillomavirus, and evaluation for
loss of heterozygosity on 1p, 3p, 11q, and
17p. Cancer 83: 1391-1400.
1762. Manson CM, Hirsch PJ, Coyne JD
(1995). Post-operative spindle cell nodule
of the vulva. Histopathology 26: 571-574.
1763. Mansour EG, Ravdin PM, Dressler L
(1994). Prognostic factors in early breast
carcinoma. Cancer 74: 381-400.
1764. Marchal C, Weber B, de Lafontan B,
Resbeut M, Mignotte H, du Chatelard PP,
Cutuli B, Reme-Saumon M, Broussier-
Leroux A, Chaplain G, Lesaunier F,
Dilhuydy JM, Lagrange JL (1999). Nine
breast angiosarcomas after conservative
treatment for breast carcinoma: a survey
from French comprehensive Cancer
Centers. Int J Radiat Oncol Biol Phys 44:
113-119.
1765. Marchese MJ, Liskow AS, Crum CP,
McCaffrey RM, Frick HC (1984). Uterine
sarcomas: a clinicopathologic study, 1965-
1981. Gynecol Oncol 18: 299-312.
1766. Marchetti A, Buttitta F, Pellegrini S,
Campani D, Diella F, Cecchetti D, Callahan
R, Bistocchi M (1993). p53 mutations and
histological type of invasive breast carcinoma.
Cancer Res 53: 4665-4669.
1767. Marcus JN, Watson P, Page DL,
Narod SA, Lenoir GM, Tonin P, Linder-
Stephenson L, Salerno G, Conway TA,
Lynch HT (1996). Hereditary breast cancer:
pathobiology, prognosis, and BRCA1 and
BRCA2 gene linkage. Cancer 77: 697-709.
1768. Marcus VA, Madlensky L, Gryfe R,
Kim H, So K, Millar A, Temple LK, Hsieh E,
Hiruki T, Narod S, Bapat BV, Gallinger S,
Redston M (1999). Immunohistochemistry
for hMLH1 and hMSH2: a practical test for
DNA mismatch repair-deficient tumors.
Am J Surg Pathol 23: 1248-1255.
1769. Marquis ST, Rajan JV, Wynshaw-
Boris A, Xu J, Yin GY, Abel KJ, Weber BL,
Chodosh LA (1995). The developmental
pattern of Brca1 expression implies a role
in differentiation of the breast and other
tissues. Nat Genet 11: 17-26.
1770. Marsden DE, Friedlander M, Hacker
NF (2000). Current management of epithelial
ovarian carcinoma: a review. Semin
Surg Oncol 19: 11-19.
1771. Marsh DJ, Coulon V, Lunetta KL,
Rocca-Serra P, Dahia PL, Zheng Z, Liaw D,
Caron S, Duboue B, Lin AY, Richardson AL,
Bonnetblanc JM, Bressieux JM, Cabarrot-
Moreau A, Chompret A, Demange L, Eeles
RA, Yahanda AM, Fearon ER, Fricker JP,
Gorlin RJ, Hodgson SV, Huson S, Lacombe
D, Leprat F, Odent S, Toulouse C, Olopade
OI, Sobol H, Tishler S, Woods CG, Robinson
BG, Weber HC, Parsons R, Peacocke M,
Longy M, Eng C. (1998). Mutation spectrum
and genotype-phenotype analyses in
Cowden disease and Bannayan-Zonana
syndrome, two hamartoma syndromes
with germline PTEN mutation. Hum Mol
Genet 7: 507-515.
1772. Marsh DJ, Dahia PL, Caron S, Kum
JB, Frayling IM, Tomlinson IP, Hughes KS,
Eeles RA, Hodgson SV, Murday VA,
Houlston R, Eng C (1998). Germline PTEN
mutations in Cowden syndrome-like families.
J Med Genet 35: 881-885.
1773. Marsh DJ, Dahia PL, Zheng Z, Liaw D,
Parsons R, Gorlin RJ, Eng C (1997).
Germline mutations in PTEN are present in
Bannayan-Zonana syndrome. Nat Genet
16: 333-334.
1774. Marsh DJ, Kum JB, Lunetta KL,
Bennett MJ, Gorlin RJ, Ahmed SF,
Bodurtha J, Crowe C, Curtis MA, Dasouki
M, Dunn T, Feit H, Geraghty MT, Graham
JM Jr., Hodgson SV, Hunter A, Korf BR,
Manchester D, Miesfeldt S, Murday VA,
Nathanson KL, Parisi M, Pober B, Romano
C, Tolmie JL, Trembath R, Winter RM,
Zackai EH, Zori RT, Weng LP, Dahia PLM,
Eng C (1999). PTEN mutation spectrum and
genotype-phenotype correlations in
Bannayan-Riley-Ruvalcaba syndrome suggest
a single entity with Cowden syndrome.
Hum Mol Genet 8: 1461-1472.
1774a. Marsh WL, Jr., Lucas JG, Olsen J
(1989). Chondrolipoma of the breast. Arch
Pathol Lab Med 113: 369-371
1775. Marshall LM, Hunter DJ, Connolly JL,
Schnitt SJ, Byrne C, London SJ, Colditz GA
(1997). Risk of breast cancer associated
with atypical hyperplasia of lobular and
ductal types. Cancer Epidemiol
Biomarkers Prev 6: 297-301.
1776. Marshall RJ, Braye SG, Jones DB
(1986). Leiomyosarcoma of the uterus with
giant cells resembling osteoclasts. Int J
Gynecol Pathol 5: 260-268.
1777. Martin-Hirsch PL, Paraskevaidis E,
Kitchener H (2001). Surgery for cervical
intraepithelial neoplasia ( C o c h r a n e
Review). The Cochrane Library.
1778. Martinelli G, Govoni E, Pileri S,
Grigioni FW, Doglioni C, Pelusi G (1983).
Sclerosing stromal tumor of the ovary. A
hormonal, histochemical and ultrastructural
study. Virchows Arch A Pathol Anat
Histopathol 402: 155-161.
1779. Martinez A, Walker RA, Shaw JA,
Dearing SJ, Maher ER, Latif F (2001).
Chromosome 3p allele loss in early invasive
breast cancer: detailed mapping and
association with clinicopathological features.
Mol Pathol 54: 300-306.
1780. Martinez V, Azzopardi JG (1979).
Invasive lobular carcinoma of the breast:
incidence and variants. Histopathology 3:
467-488.
1781. Martino A, Zamparelli M, Santinelli A,
Cobellis G, Rossi L, Amici G (2001). Unusual
clinical presentation of a rare case of phyllodes
tumor of the breast in an adolescent
girl. J Pediatr Surg 36: 941-943.
1782. Mascarello JT, Cajulis TR, Billman
GF, Spruce WE (1993). Ovarian germ cell
tumor evolving to myelodysplasia. Genes
Chromosomes Cancer 7: 227-230.
1783. Massarelli G, Bosincu L, Costanzi G,
Onida GA (1999). Uterine Wilms' tumor. Int
J Gynecol Pathol 18: 402-403.
1784. Matanoski GM, Breysse PN, Elliott
EA (1991). Electromagnetic field exposure
and male breast cancer. Lancet 337: 737.
1785. Mathoulin-Portier MP, Penault-
Llorca F, Labit-Bouvier C, Charafe E, Martin
F, Hassoun J, Jacquemier J (1998).
Malignant mullerian mixed tumor of the
uterine cervix with adenoid cystic component.
Int J Gynecol Pathol 17: 91-92.
1786. Matias-Guiu X, Bussaglia E, Catasus
L, Lagarda H, Gras E, Machin P, Prat J
(2000). Correspondence re: W.M. Lin et al.,
loss of heterozygosity and mutational
analysis of the PTEN/MMAC1 gene in syn -
chronous endometrial and ovarian carcinomas.
Clin. Cancer Res., 4: 2577-2583,
1998. Clin Cancer Res 6: 1598-1600.
1787. Matias-Guiu X, Catasus L, Bussaglia
E, Lagarda H, Garcia A, Pons C, Munoz J,
Arguelles R, Machin P, Prat J (2001).
Molecular pathology of endometrial hyperplasia
and carcinoma. Hum Pathol 32: 569-
577.
1788. Matias-Guiu X, Lagarda H, Catasus
LI, Bussaglia E, Gallardo A, Gras E, Prat J
(2002). Clonality analysis in synchronous or
metachronous tumors of the female genital
tract. Int J Gynecol Pathol 21: 205-211.
1789. Matias-Guiu X, Pons C, Prat J (1998).
Mullerian inhibiting substance, alphainhibin,
and CD99 expression in sex cordstromal
tumors and endometrioid ovarian
carcinomas resembling sex cord-stromal
tumors. Hum Pathol 29: 840-845.
1790. Matias-Guiu X, Prat J (1990). Ovarian
tumors with functioning stroma. An
immunohistochemical study of 100 cases
with human chorionic gonadotropin monoclonal
and polyclonal antibodies. Cancer
65: 2001-2005.
1791. Matsuoka S, Huang M, Elledge SJ
(1998). Linkage of ATM to cell cycle regulation
by the Chk2 protein kinase. Science
282: 1893-1897.
1792. Mattia AR, Ferry JA, Harris NL (1993).
Breast lymphoma. A B-cell spectrum
including the low grade B-cell lymphoma
of mucosa associated lymphoid tissue. Am
J Surg Pathol 17: 574-587.
1793. Mauillon JL, Michel P, Limacher JM,
Latouche JB, Dechelotte P, Charbonnier F,
Martin C, Moreau V, Metayer J, Paillot B,
Frebourg T (1996). Identification of novel
germline hMLH1 mutations including a 22
kb Alu-mediated deletion in patients with
familial colorectal cancer. Cancer Res 56:
5728-5733.
1794. Mauz-Korholz C, Harms D, Calaminus
G, Gobel U (2000). Primary chemotherapy
and conservative surgery for vaginal yolksac
tumour. Maligne Keimzelltumoren
Study Group. Lancet 355: 625.
1795. Mawhinney RR, Powell MC,
Worthington BS, Symonds EM (1988).
Magnetic resonance imaging of benign
ovarian masses. Br J Radiol 61: 179-186.
1796. Mayall F, Rutty K, Campbell F,
Goddard H (1994). p53 immunostaining
suggests that uterine carcinosarcomas
are monoclonal. Histopathology 24: 211-
214.
1797. Mayerhofer K, Obermair A,
Windbichler G, Petru E, Kaider A, Hefler L,
Czerwenka K, Leodolter S, Kainz C (1999).
Leiomyosarcoma of the uterus: a clinicopathologic
multicenter study of 71 cases.
Gynecol Oncol 74: 196-201.
1798. Maymon E, Piura B, Mazor M, Bashiri
A, Silberstein T, Yanai-Inbar I (1998).
Primary hepatoid carcinoma of ovary in
pregnancy. Am J Obstet Gynecol 179: 820-
822.
1799. Mayorga M, Garcia-Valtuille A,
Fernandez I, et al. (1997). Adenocarcinoma
of the uterine cervix with massive signetring
cell differentiation. Int J Surg Pathol 5:
95-100.
1800. Mazoujian G, Pinkus GS, Davis S,
Haagensen DE Jr. (1983). Immunohistochemistry
of a gross cystic disease
fluid protein (GCDFP-15) of the breast. A
marker of apocrine epithelium and breast
carcinomas with apocrine features. Am J
Pathol 110: 105-112.
1801. Mazur MT (1981). Atypical polypoid
adenomyomas of the endometrium. Am J
Surg Pathol 5: 473-482.
1801a. Mazur MT (1989). Metastatic gestational
choriocarcinoma. Unusual pathologic
variant following therapy. Cancer 63:
1370-1377.
1802. Mazur MT, Hsueh S, Gersell DJ
(1984). Metastases to the female genital
tract. Analysis of 325 cases. Cancer 53:
1978-1984.
1802a. Mazur MT, Lurain JR, Brewer JI
(1982). Fatal gestational choriocarcinoma.
Clinicopathologic study of patients treated
at a trophoblastic disease center. Cancer
50: 1833-1846.
1803. Mazzella FM, Sieber SC, Braza F
(1995). Ductal carcinoma of male breast
with prominent lipid-rich component.
Pathology 27: 280-283.
1804. McAdam JA, Stewart F, Reid R (1998).
Vaginal epithelioid angiosarcoma. J Clin
Pathol 51: 928-930.
1805. McBride CM, Hortobagyi GN (1985).
Primary inflammatory carcinoma of the
female breast: staging and treatment possibilities.
Surgery 98: 792-798.
1806. McCarthy JH, Aga R (1988). A fallopian
tube lesion of borderline malignancy
associated with pseudo-myxoma peritonei.
Histopathology 13: 223-225.
400 References